Barlow Wealth Partners’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$570K Hold
6,534
– – 0.06% 84
2026
Q2
$608K Hold
6,534
– – 0.07% 81
2026
Q1
$561K Sell
6,534
-162
-2% -$14.4K 0.06% 80
2025
Q4
$546K Hold
6,696
– – 0.06% 79
2025
Q3
$535K Hold
6,696
– – 0.06% 81
2025
Q2
$619K Hold
6,696
– – 0.07% 73
2025
Q1
$629K Buy
6,696
+334
+5% +$29.9K 0.08% 71
2024
Q4
$559K Hold
6,362
– – 0.07% 78
2024
Q3
$627K Hold
6,362
– – 0.08% 78
2024
Q2
$615K Hold
6,362
– – 0.09% 75
2024
Q1
$546K Hold
6,362
– – 0.07% 82
2023
Q4
$507K Buy
+6,362
New +$478K 0.07% 86

Other funds holding CL

Barlow Wealth Partners's CL Position: Q3 2026 in Review

Barlow Wealth Partners held its Colgate-Palmolive (CL) position steady in Q3 2026 at 6,534 shares worth $570K. The position accounts for 0.06% of the portfolio, ranked #84.

Barlow Wealth Partners first reported a position in CL in Q4 2023 and has held it in 12 quarters since. The position peaked at $629K in Q1 2025. 1,712 funds tracked by Wall St. Rank hold CL as of Q3 2026.

  • Barlow Wealth Partners held 6,534 shares of Colgate-Palmolive worth $570K as of Q3 2026.
  • Barlow Wealth Partners left its Colgate-Palmolive share count unchanged in Q3 2026.
  • Colgate-Palmolive made up 0.06% of Barlow Wealth Partners's portfolio in Q3 2026, its #84 holding.
  • Barlow Wealth Partners first reported a position in Colgate-Palmolive in Q4 2023 and has held it in 12 quarters since.
  • Barlow Wealth Partners's Colgate-Palmolive position peaked at $629K in Q1 2025.
  • 1,712 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2026.

Based on Barlow Wealth Partners's 13F filing for Q3 2026, filed 15 Oct 2026.